Leading counter-terrorism training programs developer, Universal Detection Technology, announced that it has received a U.S. patent for its automated airborne anthrax detection system. Titled “Apparatus and Method for Automated Monitoring of Bacterial Spores,” the invention has been filed under USPTO number US 7,563,615 B2 and describes an apparatus and method for automated monitoring of airborne bacterial spores.

The apparatus includes an air sampler, a surface for capturing bacterial spores, a source of lanthanide ions, and a spectrometer for excitation and detection of the spores’ characteristic fluorescence. In accordance with the method, computer-programmed steps allow for automation of the apparatus for monitoring purposes.

The issuance marks the company’s second patent for technology licensed by the California Institute of Technology. The granted patent supplements the 2007 patent for providing intellectual property rights for the automated detection of airborne bacterial spores. Universal Detection Technology’s BSM-2000 utilizes both technologies in its monitoring of airborne hazards.

“Universal Detection Technology’s second patent on its licensed technology is another step forward in providing critical counter-bioterrorism equipment to organizations in the public, commercial and private sectors,” said Universal Detection Technology CEO Jacques Tizabi. “This distinction will allow us to continue to bolster our intellectual property rights in the U.S. and abroad.”